Projects

Mgr. Barbora Valúchová

National

Current
  • Targeting SERCA Activation: The impact of Novel Derivatives of Cemtirestat on Enhanced Pancreatic Beta-Cell Function in Diabetes Management
    Program: VEGA
    Duration: 1. 1. 2026 – 31. 12. 2029
  • Modulating SERCA Pump Activity: Biochemical Studies in Isolated SERCA1a Enzyme and Pancreatic Beta-Cells.
    Program: VEGA
    Duration: 1. 1. 2026 – 31. 12. 2029
  • Pharmacological Activation of SERCA: A Therapeutic Target for Chronic Metabolic Diseases
    Program: SRDA
    Duration: 1. 9. 2025 – 31. 8. 2029
  • Targeting SERCA Activation: Therapeutic Strategies for Managing Endoplasmic Reticulum Stress in Chronic Metabolic Diseases
    Program: VEGA
    Duration: 1. 1. 2025 – 31. 12. 2028
Finished
  • Multi-target approach to diverse molecular mechanisms of diabetic complications and other glucose toxicity related diseases
    Program: SRDA
    Duration: 1. 8. 2021 – 30. 6. 2025
  • Phenolic compounds and their semi-synthetic derivatives as therapeutic tools for endoplasmic reticulum stress regulation via SERCA pumps
    Program: VEGA
    Duration: 1. 1. 2021 – 31. 12. 2024
  • Novel compounds in prevention and treatment of diseases caused by glucose toxicity
    Program: VEGA
    Duration: 1. 1. 2018 – 31. 12. 2021
Employees